Xiaohui Guo

4.3k total citations · 1 hit paper
21 papers, 3.0k citations indexed

About

Xiaohui Guo is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Xiaohui Guo has authored 21 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 4 papers in Epidemiology. Recurrent topics in Xiaohui Guo's work include Diabetes Management and Research (5 papers), Diabetes Management and Education (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Xiaohui Guo is often cited by papers focused on Diabetes Management and Research (5 papers), Diabetes Management and Education (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Xiaohui Guo collaborates with scholars based in China, United States and Philippines. Xiaohui Guo's co-authors include Linong Ji, Juming Lu, Jianping Weng, Weiping Jia, Li Chen, Jiapu Ge, Zhongyan Shan, Haoming Tian, Qiuhe Ji and Lixiang Lin and has published in prestigious journals such as New England Journal of Medicine, Scientific Reports and Biomedicine & Pharmacotherapy.

In The Last Decade

Xiaohui Guo

21 papers receiving 2.9k citations

Hit Papers

Prevalence of Diabetes among Men and Women in China 2010 2026 2015 2020 2010 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohui Guo China 12 1.5k 638 620 400 392 21 3.0k
Jianzhong Xiao China 19 1.6k 1.1× 864 1.4× 716 1.2× 598 1.5× 543 1.4× 63 3.9k
Zhigang Zhao China 10 1.3k 0.9× 642 1.0× 594 1.0× 406 1.0× 408 1.0× 29 2.8k
Jiapu Ge China 8 1.4k 0.9× 612 1.0× 630 1.0× 382 1.0× 413 1.1× 11 2.8k
Josep Franch‐Nadal Spain 30 1.9k 1.3× 404 0.6× 660 1.1× 338 0.8× 582 1.5× 228 3.3k
Stavroula Α. Paschou Greece 37 1.6k 1.1× 911 1.4× 637 1.0× 732 1.8× 481 1.2× 200 4.7k
Qiuhe Ji China 24 2.0k 1.4× 1.0k 1.6× 816 1.3× 600 1.5× 535 1.4× 75 4.2k
Eric S. H. Lau Hong Kong 26 1.2k 0.8× 389 0.6× 424 0.7× 323 0.8× 282 0.7× 109 2.2k
Andrea O. Y. Luk Hong Kong 33 2.3k 1.5× 758 1.2× 1.1k 1.8× 642 1.6× 569 1.5× 188 4.2k
Juming Lu China 24 2.1k 1.4× 1.0k 1.6× 774 1.2× 711 1.8× 629 1.6× 94 4.3k

Countries citing papers authored by Xiaohui Guo

Since Specialization
Citations

This map shows the geographic impact of Xiaohui Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohui Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohui Guo more than expected).

Fields of papers citing papers by Xiaohui Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohui Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohui Guo. The network helps show where Xiaohui Guo may publish in the future.

Co-authorship network of co-authors of Xiaohui Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohui Guo. A scholar is included among the top collaborators of Xiaohui Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohui Guo. Xiaohui Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qianyi, et al.. (2025). Mechanism and therapeutic potential of hippo signaling pathway in type 2 diabetes and its complications. Biomedicine & Pharmacotherapy. 183. 117817–117817. 1 indexed citations
2.
Lu, Difei, et al.. (2024). Immune checkpoint inhibitor-associated new-onset hypophysitis: a retrospective analysis using the FAERS. Endocrine. 86(1). 342–348. 2 indexed citations
3.
Guo, Xiaohui, Yang Yu, Yongbo Zhang, et al.. (2024). A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled 14-Week Study of Mirogabalin in Chinese Patients with Diabetic Peripheral Neuropathic Pain. Pain and Therapy. 13(4). 937–952. 3 indexed citations
4.
Lü, Qian, Dong Pang, Ping Yang, et al.. (2020). Foot Care Education Among Patients With Diabetes Mellitus in China. Journal of Wound Ostomy and Continence Nursing. 47(3). 276–283. 7 indexed citations
5.
Zhang, Yang, Haichao Li, Jian Zhang, et al.. (2020). The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single‐centre, retrospective, observational study in Wuhan. Diabetes Obesity and Metabolism. 22(8). 1443–1454. 135 indexed citations
6.
Zheng, Jia, Jing Cheng, Sheng Zheng, et al.. (2018). Physical Exercise and Its Protective Effects on Diabetic Cardiomyopathy: What Is the Evidence?. Frontiers in Endocrinology. 9. 729–729. 46 indexed citations
7.
Ren, Yanfeng, Leili Gao, Xiaohui Guo, et al.. (2018). Interactive effect of serum uric acid and total bilirubin for micro-vascular disease of type 2 diabetes in China. Journal of Diabetes and its Complications. 32(11). 1000–1005. 15 indexed citations
8.
Zou, Xiantong, Xianghai Zhou, Linong Ji, et al.. (2017). The characteristics of newly diagnosed adult early-onset diabetes: a population-based cross-sectional study. Scientific Reports. 7(1). 46534–46534. 45 indexed citations
9.
Ji, Linong, Xiaohui Guo, Lixin Guo, et al.. (2016). A Multicenter Evaluation of the Performance and Usability of a Novel Glucose Monitoring System in Chinese Adults With Diabetes. Journal of Diabetes Science and Technology. 11(2). 290–295. 49 indexed citations
10.
Xu, Wen, Sihui Luo, Ming Li, et al.. (2015). Status of basal‐supported oral therapy in Chinese type 2 diabetic patients with inadequate glycemic control on oral anti‐diabetic drugs. Diabetes/Metabolism Research and Reviews. 31(8). 796–802. 2 indexed citations
11.
12.
Li, Yuan, Xiaohui Guo, Zhenzhen Xiong, et al.. (2014). Self-monitoring of blood glucose in type 2 diabetic patients in China: current status and influential factors. Chinese Medical Journal. 127(2). 201–207. 20 indexed citations
13.
Guo, Xiaohui, Yuan Li, Qingqing Lou, et al.. (2012). A nationwide survey of diabetes education, self-management and glycemic control in patients with type 2 diabetes in China.. PubMed. 125(23). 4175–80. 73 indexed citations
16.
Guo, Xiaohui. (2011). Expression of aquaporin 7 in perirenal adipose tissue of Otsuka Long-Evans Tokushima Fatty diabetic rats. 1 indexed citations
17.
Yang, Wenying, Juming Lu, Jianping Weng, et al.. (2010). Prevalence of Diabetes among Men and Women in China. New England Journal of Medicine. 362(12). 1090–1101. 2488 indexed citations breakdown →
18.
Gao, Yan, Changyu Pan, Dajin Zou, et al.. (2009). [Postprandial glycemic control using insulin aspart with NPH in inadequately controlled diabetics].. PubMed. 89(28). 1960–3. 5 indexed citations
19.
Gao, Ying, et al.. (2007). Follow‐up of avidity and titre of anti‐myeloperoxidase antibodies in sera from patients with propylthiouracil‐induced vasculitis. Clinical Endocrinology. 66(4). 543–547. 18 indexed citations
20.
Gao, Ying, Ming‐Hui Zhao, Xiaohui Guo, et al.. (2004). The Prevalence and Target Antigens of Antithyroid Drugs Induced Antineutrophil Cytoplasmic Antibodies (ANCA) in Chinese Patients with Hyperthyroidism. Endocrine Research. 30(2). 205–213. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026